Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease

Circulation Journal

Volumn 74, Issue 3, 2010, Pages 449-455

  Shimizu, Tsuyoshi ^a   Ohno, Takayuki ^b   Ando, Jiro ^a   Fujita, Hideo ^a   Nagai, Ryozo ^a   Motomura, Noboru ^a   Ono, Minoru ^a   Kyo, Shunei ^a   Takamoto, Shinichi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Coronary artery bypass; Coronary artery disease; Drug eluting stents; Percutaneous coronary intervention

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HOSPITAL COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; STROKE; SURVIVAL RATE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL COSTS; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 77649213993     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0586     Document Type: Article

References (35)

1. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008; 118: 1146-1154.
2. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Sigwart U, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: Six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008; 118: 381-388.
3. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 46: 575-581.
4. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007; 357: 1393-1402.
5. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, et al. Drug-eluting stents vs coronary-artery bypass grafting in multi-vessel coronary disease. N Engl J Med 2008; 358: 331-341.
6. Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007; 116(Suppl): I-200-I-206.
7. Yan Q, Changsheng M, Shaoping N, Xiaohui L, Junping K, Qiang L, et al. Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multi-vessel disease involving significant proximal stenosis in left anterior descending artery. Circ J 2009; 73: 1848-1855.
8. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 2008; 117: 2079-2086.
9. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007; 356: 1009-1019.
10. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: The DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 2008; 51: 2212-2219.
11. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation 2009; 119: 1330-1352.
12. Puskas JD, Kilgo PD, Lattouf OM, Thourani VH, Cooper WA, Vassiliades TA, et al. Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival. Ann Thorac Surg 2008; 86: 1139-1146; discussion 1146.
13. Ueda Y, Fujii Y, Kuwano H. Thoracic and cardiovascular surgery in Japan during 2007: Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2009; 57: 488-513.
14. Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders LD, et al. Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Am Heart J 2001; 142: 119-126.
15. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006; 47: 864-870.
16. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006; 98: 54-59.
17. Cheng CI, Lee FY, Chang JP, Hsueh SK, Hsieh YK, Fang CY, et al. Long-term outcomes of intervention for unprotected left main coronary artery stenosis: coronary stenting vs coronary artery bypass grafting. Circ J 2009; 73: 705-712.
18. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008; 358: 1781-1792.
19. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
20. Stamou SC, Jablonski KA, Hill PC, Bafi AS, Boyce SW, Corso PJ. Coronary revascularization without cardiopulmonary bypass versus the conventional approach in high-risk patients. Ann Thorac Surg 2005; 79: 552-557.
21. Dewey TM, Magee MJ, Edgerton JR, Mathison M, Tennison D, Mack MJ. Off-pump bypass grafting is safe in patients with left main coronary disease. Ann Thorac Surg 2001; 72: 788-791; discussion 792.
22. Mizutani S, Matsuura A, Miyahara K, Eda T, Kawamura A, Yoshioka T, et al. On-pump beating-heart coronary artery bypass: A propensity matched analysis. Ann Thorac Surg 2007; 83: 1368-1373.
23. Katsuki T. What is the best way to treat left main coronary artery disease? Circ J 2009; 73: 626-627.
24. Hannan EL, Wu C, Smith CR, Higgins RS, Carlson RE, Culliford AT, et al. Off-pump versus on-pump coronary artery bypass graft surgery: Differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation 2007; 116: 1145-1152.
25. Takahashi S, Kaneda H, Tanaka S, Miyashita Y, Shiono T, Taketani Y, et al. Late angiographic stent thrombosis after sirolimus-eluting stent implantation. Circ J 2007; 71: 226-228.
26. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused Update of the ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008; 117: 261-295.
27. Brunner-La Rocca HP, Kaiser C, Bernheim A, Zellweger MJ, Jeger R, Buser PT, et al. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): An 18-month analysis. Lancet 2007; 370: 1552-1559.
28. Filion KB, Roy AM, Baboushkin T, Rinfret S, Eisenberg MJ. Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis. Am J Cardiol 2009; 103: 338-344.
29. Stroupe KT, Morrison DA, Hlatky MA, Barnett PG, Cao L, Lyttle C, et al. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of highrisk patients. Circulation 2006; 114: 1251-1257.
30. Hlatky MA, Boothroyd DB, Melsop KA, Brooks MM, Mark DB, Pitt B, et al. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation 2004; 110: 1960-1966.
31. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117-1124.
32. Wang X, Rokoss M, Dyub A, Gafni A, Lamy A. Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease. J Med Econ 2008; 11: 119-134.
33. Rao C, Aziz O, Panesar SS, Jones C, Morris S, Darzi A, et al. Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007; 334: 621.
34. Lamy A, Wang X, Farrokhyar F, Kent R. A cost comparison of off-pump CABG versus on-pump CABG at one-year: The Canadian off-pump CABG registry. Can J Cardiol 2006; 22: 699-704.
35. Yasunaga H, Ide H, Imamura T, Ohe K. Price disparity of percutaneous coronary intervention devices in Japan and the United States in 2006. Circ J 2007; 71: 1128-1130.